Anti-platelets Flashcards

1
Q

Name the types of anti-platelets

A

Cyclo-oxygenase inhibitor

P2Y12/ADP receptor inhibitor

Glycoprotein IIb/IIIa inhibitor

Phosphodiesterase inhibitor

Fibrinolytic agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When should antiplatelets be used and what do they do

A

Antiplatelets shuold be used on platelet rich, arterial thrombi

Antiplatelets inhibit platelet aggregation -> prevent arterial thrombus formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do cyclo-oxygenase inhibitors work

A

Cyclo-oxygenase inhibitors prevent COX-1 from forming thromboxane A2 to prevent aggregation

Irreversible inhibition - inhibition lasts as long as the platelet lifespan

Action at low dose has antiplatelet effects while at high doses has an analgesic effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Name a cyclo-oxygenase inhibitor

A

Aspirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name some indications for the use of a cyclo-oxygenase inhibitor

A

Secondary prevention of stroke and TIA if other agents contraindicated

Secondary prevention of actue coronary syndrome

Post primary percutaneous coronary intervention and stent to reduce ischaemic complications

Secondary prevention of MI in stable angina and peripheral vascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do P2Y12/ADP receptor antagonists work and give some examples

A

These inhibit binding of ADP to P2Y12 receptors to inhibit activation of GPIIb/IIIa receptors

E.g. clopidogrel, prasugrel, ticagrelor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe when clopidogrel is used

A

Clopidogrel has slow mode of action without a loading dose

It reduces mortality and morbidity post thromboembolic stroke

Reduces secondary events post MI

Prophylaxis in patients intolerant to aspirin

Typically used for 12mths post MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do glycoprotein IIb/IIIa inhibitors work and give some examples

A

These drugs target the binding of fibrinogen and vWF, and also target the final common pathway to compete with platelet aggregation

E.g. abciximab, tirofiban, eptifbatide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe how abciximab works

A

Abciximab is a monoclonal antibody that irreversibly blocks GPIIb/IIIa receptors to prevent fibrinogen bidning

Causes >80% reduction in aggregation but has high risk of bleeding

Slow to dissociate -> gives long mode of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is a side effect of GPIIb/IIIa inhibitor use

A

Thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do phosphodiesterase inhibitors work

A

Inhibit cellular reuptake of adenosine so have increased plasma adenosine which inhibits platelet aggregation via A2 receptors

Acts as phosphodiesterase inhibitor to prevent cAMP and cGMP degradation which inhibits expression of GPIIb/IIIa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name a phosphodiesterase inhibitor

A

Dipyridamole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name some uses and side effects of phosphodiesterase inhibitors

A

Uses: secondary prevention of ischaemic stroke and TIAs. Prophylaxis of thromboembolism following valve replacement

Side effects: vasodilation causing flushing and headaches. Hypersensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do fibrinolytic agents work

A

Fibrinolytic agents wok by dissolving the firbin meshwork of the thrombus to break the clot down

Given either IV or IA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Name some fibrinolytic agents

A

Streptokinase - antigenic -> given once

Alteplase

Reteplase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is tranexamic acid

A

Tranexamic acid is a drug that inhibits fibrinolysis to prevent blood loss

It inhibits plasminogen activation